by newsworm | Mar 5, 2025 | Pharma, Piramal Pharma
Piramal Enterprises Ltd (PEL) has received a tax demand notice from the Maharashtra Goods and Services Tax (GST) department for Rs. 1,502 crore, allegedly for short payment and non-payment of tax, interest, and penalties on the sale of its pharma business to Piramal... by newsworm | Mar 4, 2025 | Pharma, Piramal Pharma
Farhat Nasim is a dedicated editor for the Business Section of Medical Dialogues, a prominent online publication, since 2017. She is responsible for covering the latest developments and updates in the pharmaceutical industry, as well as policy, insurance, business,... by newsworm | Mar 3, 2025 | Aurobindo Pharma, Pharma, Piramal Pharma
Here is a summary of the content in 400 words: IIFL Finance has approved the issuance of secured, listed, rated, and redeemable non-convertible debentures worth Rs 150 crore, with a base issue of Rs 75 crore and an additional greenshoe option of Rs 75 crore. This will... by newsworm | Feb 27, 2025 | Pharma, Piramal Pharma
India’s contract research and development manufacturing organization (CRDMO) sector is on the cusp of significant growth, with potential to expand seven-fold to $22-25 billion by 2035. The sector, which is currently valued at $35-40 billion, is expected to play... by newsworm | Feb 22, 2025 | Pharma, Piramal Pharma
Piramal Pharma Limited’s facility at Turbhe in India has received a Form-483 from the US FDA after a recent General GMP (Good Manufacturing Practice) inspection. The inspection, which took place from February 11th to February 17th, 2025, resulted in 6... by newsworm | Feb 20, 2025 | Pharma, Piramal Pharma
The US Food and Drug Administration (FDA) has issued six observations for Piramal Pharma’s Turbhe facility. The facility is known for producing various pharmaceutical products, including generic drugs and active pharmaceutical ingredients (APIs). The...